Exchange: NYSE·Updated 07:31 PM EDT

AGRO News

News
all
press releases
Fitch Ratings Initiates Coverage of Adecoagro with a BB Corporate Credit Rating and Stable Outlook
Fitch Ratings Initiates Coverage of Adecoagro with a BB Corporate Credit Rating and Stable Outlook Fitch Ratings Initiates Coverage of Adecoagro with a BB Corporate Credit Rating and Stable OutlookPR NewswireLUXEMBOURG, September 18, 2026 LUXEMBOURG, September 18, 2026 /PRNewswire/ -- Adecoagro...
PR Newswire
More News
Can Ethanol Momentum Fuel Archer Daniels' Carbohydrate Growth?
ADM's ethanol momentum is boosting Carbohydrate Solutions as stronger margins and policy incentives offset pressure in liquid sweeteners.
Zacks
Archer Daniels Targets $500M-$750M in Savings: Can It Deliver?
ADM's cost-cutting drive targets $500-$750 million in savings, with early progress and stronger profits signaling efficiency gains.
Zacks
Can Flavors Keep Driving Archer Daniels' Human Nutrition Growth?
ADM's Flavors business is driving Human Nutrition growth as strong beverage demand, Asia Pacific gains and innovation lift profits.
Zacks
Adecoagro Completes Acquisition of Caarap Mill and Integrates It Into Its Cluster in Mato Grosso do Sul
Adecoagro Completes Acquisition of Caarap Mill and Integrates It Into Its Cluster in Mato Grosso do Sul Adecoagro Completes Acquisition of Caarap Mill and Integrates It Into Its Cluster in Mato Grosso do Sul PR Newswire LUXEMBOURG, Sept. 1, 2026 LUXEMBOURG, Sept. 1, 2026 /PRNewswire/ -- Adecoagro...
PR Newswire
Here's Why the Calavo Integration Matters for Mission Produce's Growth
AVO's Calavo integration expands scale, sourcing and customer reach, with synergies and prepared foods adding growth potential.
Zacks
AVO Stock Looks Expensive: Buy Now or Wait for Better Entry Point?
Mission Produce's premium valuation and recent momentum highlight growth plans, Calavo acquisition benefits and risks from margin pressure.
Zacks
Archer Daniels' Stock Surges 20.6% in Six Months: Is It Time to Buy or Wait?
ADM's earnings recovery, biofuel tailwinds and improving Nutrition business support its rally, while valuation and execution remain in focus.
Zacks
Corteva's Higher 2026 Guidance Puts Investor Focus on Growth Drivers
CTVA's Q2 earnings beat and raised 2026 outlook signal progress, but Crop Protection pricing and separation risks remain.
Zacks
Corteva Growth Improves, But Valuation Limits Upside
CTVA's stronger earnings outlook is supported by Seed growth and productivity gains, but Crop Protection pricing and separation risks persist.
Zacks

Advertisement|Remove ads.